FFA
KYMR icon

Farther Finance Advisors’s Kymera Therapeutics KYMR Stock Holding History

Farther Finance Advisors’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.4K Buy
178
+2
+1% +$172 ﹤0.01% 3952
2026
Q1 		$14.9K Buy
176
+11
+7% +$871 ﹤0.01% 3847
2025
Q4 		$12.8K Buy
165
+81
+96% +$5.47K ﹤0.01% 3743
2025
Q3 		$4.75K Sell
84
-540
-87% -$24.4K ﹤0.01% 3786
2025
Q2 		$27.2K Buy
624
+540
+643% +$18.6K ﹤0.01% 2482
2025
Q1 		$2.12K Hold
84
– – ﹤0.01% 3369
2024
Q4 		$3.38K Buy
84
+70
+500% +$3.16K ﹤0.01% 2831
2024
Q3 		$663 Buy
14
+6
+75% +$265 ﹤0.01% 3355
2024
Q2 		$248 Hold
8
– – ﹤0.01% 3450
2024
Q1 		$315 Hold
8
– – ﹤0.01% 3156
2023
Q4 		$204 Buy
+8
New +$143 ﹤0.01% 3223

Other funds holding KYMR

PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
KMWM
Keudell/Morrison Wealth Management Salem, Oregon $529M AUM
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
DWM
Drive Wealth Management Lehi, Utah $561M AUM 33.14% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Farther Finance Advisors's KYMR Position: Q2 2026 in Review

Farther Finance Advisors increased its Kymera Therapeutics (KYMR) stake by 1.1% in Q2 2026, buying an estimated $172 and bringing the position to 178 shares worth $20.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3952.

Farther Finance Advisors first reported a position in KYMR in Q4 2023 and has held it in 11 quarters since. The position peaked at $27.2K in Q2 2025. 25 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Farther Finance Advisors held 178 shares of Kymera Therapeutics worth $20.4K as of Q2 2026.
  • Farther Finance Advisors bought 2 Kymera Therapeutics shares in Q2 2026, an estimated $172.
  • Kymera Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3952 holding.
  • Farther Finance Advisors first reported a position in Kymera Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • Farther Finance Advisors's Kymera Therapeutics position peaked at $27.2K in Q2 2025.
  • 25 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.